<code id='1FFD5418B4'></code><style id='1FFD5418B4'></style>
    • <acronym id='1FFD5418B4'></acronym>
      <center id='1FFD5418B4'><center id='1FFD5418B4'><tfoot id='1FFD5418B4'></tfoot></center><abbr id='1FFD5418B4'><dir id='1FFD5418B4'><tfoot id='1FFD5418B4'></tfoot><noframes id='1FFD5418B4'>

    • <optgroup id='1FFD5418B4'><strike id='1FFD5418B4'><sup id='1FFD5418B4'></sup></strike><code id='1FFD5418B4'></code></optgroup>
        1. <b id='1FFD5418B4'><label id='1FFD5418B4'><select id='1FFD5418B4'><dt id='1FFD5418B4'><span id='1FFD5418B4'></span></dt></select></label></b><u id='1FFD5418B4'></u>
          <i id='1FFD5418B4'><strike id='1FFD5418B4'><tt id='1FFD5418B4'><pre id='1FFD5418B4'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:31134
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In